Results 131 to 140 of about 11,219,681 (307)

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Chemical and Biomolecular Engineering Departmental Newsletter - Fall 2016

open access: yes, 2016
This quarterly newsletter provides information on students, faculty, alumni, and events from the Chemical and Biomolecular Engineering Department at Clemson ...
Clemson University. Chemical and Biomolecular Engineering Department
core  

Chemical characterization of simulated boiling water reactor coolant [PDF]

open access: yes, 1990
Thesis (M.S.)--Massachusetts Institute of Technology, Dept. of Nuclear Engineering, 1990, and Thesis (M.S.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 1990.Includes bibliographic references (leaves 243-249).by VerrDon Holbrook
Mason, VerrDon Holbrook.   +1 more
core  

Expanding the scope of Chemical Engineering Journal Advances. [PDF]

open access: yesChem Eng J Adv, 2022
Pan B   +8 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Chemical and Biomolecular Engineering Departmental Newsletter - Fall 2019

open access: yes, 2019
This quarterly newsletter provides information on students, faculty, alumni, and events from the Chemical and Biomolecular Engineering Department at Clemson ...
Clemson University. Chemical and Biomolecular Engineering Department
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Chemical and Biomolecular Engineering Departmental Newsletter - Spring 2015

open access: yes, 2015
This quarterly newsletter provides information on students, faculty, alumni, and events from the Chemical and Biomolecular Engineering Department at Clemson ...
Clemson University. Chemical and Biomolecular Engineering Department
core  

Large‐Scale Screening of Covalent Organic Framework/Polymer Mixed‐Matrix Membranes for Advanced Gas Separations

open access: yesMacromolecular Materials and Engineering
Mixed matrix membranes (MMMs) that incorporate covalent organic frameworks (COFs) as fillers in polymers offer a promising route to overcome the permeability‐selectivity trade‐off of polymeric membranes.
Feride Neva Yungul   +2 more
doaj   +1 more source

Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease models. [PDF]

open access: yesNat Commun, 2022
Conroy F   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy